- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01101789
Triclosan Coated Suture Wound Closure for Peripheral Vascular Surgery: a Prospective Multicenter Study
October 11, 2015 updated by: Sanna Kouhia, North Karelia Central Hospital
This is a prospective randomized multicenter study which purpose is to determine whether triclosan-coated sutures for wound closure after lower limb vascular surgery would reduce the incidence of surgical wound infections.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
276
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Joensuu, Finland, 80210
- North Carelia Central Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patient undergoing peripheral vascular surgery procedure
Exclusion Criteria:
- patients refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: triclosan
triclosan-coated sutures
|
triclosan coated suture for surgical wound closure
|
|
Placebo Comparator: control
sutures without triclosan-coating
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
surgical wound infection
Time Frame: one month after surgical procedure
|
one month after surgical procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Johanna Turtiainen, MD, North Karelia Central Hospital
- Principal Investigator: Kimmo Makinen, Kuopio University Hospital
- Principal Investigator: Maarit Venermo, Helsinki University Central Hospital
- Principal Investigator: Eija Saimanen, South Carelia Central Hospital
- Study Director: Ilkka Uurto, Tampere University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
April 8, 2010
First Submitted That Met QC Criteria
April 8, 2010
First Posted (Estimate)
April 12, 2010
Study Record Updates
Last Update Posted (Estimate)
October 14, 2015
Last Update Submitted That Met QC Criteria
October 11, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Postoperative Complications
- Wounds and Injuries
- Surgical Wound
- Surgical Wound Infection
- Wound Infection
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Antimetabolites
- Hypolipidemic Agents
- Lipid Regulating Agents
- Fatty Acid Synthesis Inhibitors
- Triclosan
Other Study ID Numbers
- NKCH-surg-006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.